This article has been created as a summary of a range of material from PCRS tools and encompasses the basics of a good respiratory review.
This is a high-level summary of what the new BTS/NICE/SIGN Asthma: diagnosis monitoring and chronic asthma management guideline means for you as a primary healthcare professional and what steps you need to take to implement it effectively.
Now is the time to make MART moves for asthma. We have been using the separate blue (reliever) and brown (preventer) inhalers for far too long. The National Review of Asthma Deaths (NRAD) came out a decade ago, yet as a nation, we still have the highest asthma death rate in Europe. This is unsurprising, considering many patients still rely on their blue inhalers alone. However,
Maintenance and reliever therapy (MART) is a treatment for asthma where a single combined inhaler is used for both maintenance and reliever purposes, instead of having separate preventer (brown) and reliever (blue) inhalers.
Inhalation is the main route for administration of drugs for conditions such as asthma or chronic obstructive pulmonary disease. The advantage of administering drugs by inhaler is that drugs are delivered directly to the site of action within the airways. The onset of action is rapid and systemic adverse effects are minimised. However, for an inhaler to be effective the correct drug must be prescribed and the device must be used correctly. Poor inhaler technique is common.
This article explores the impact of the environment on the health of people with asthma and COPD and focuses on two key areas, indoor (home) and outdoor pollutants and severe weather extremes such as heat waves or very cold weather
In this article Lisa Cummings, Queens Nurse, CYP Specialist Asthma Practitioner and PCRS Education Committee member, discusses the management of asthma and atopy in children and young people focusing on perennial and allergic rhinitis, it’s impact on asthma and top tips for reducing symptoms and improving control.
This online learning module will take you through the GINA approach to managing asthma and using this, in collaboration with patients, to ensure and maintain optimal treatment for people with asthma. We will explore the GINA model and how it can be applied to facilitate best practice asthma care.We have incorporated MCQs to gauge your grasp of the module; providing clear explanations for each correct answer to enhance your understanding.
You may also be interested in...
Asthma Right Care (ARC) is a global social movement created by the International Primary Care Respiratory Group (IPCRG) to drive change and disrupt the status quo in asthma management. Here you'll find podcasts, webinars, practical guidance and patient tools to help improve asthma outcomes.
The mMRC (Modified Medical Research Council) Dyspnoea Scale is used to assess the degree of baseline functional disability due to dyspnoea.
The PCRS Greener Respiratory Healthcare Quality Improvement (QI) toolkit has been developed to support HCPs working in the primary care setting to understand and evaluate the environmental impact of their clinical practice, identify ways to reduce this impact, set goals and priorities and evaluat
Self-reported during community pharmacy consultations in London